We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A comprehensive guide to the AstraZeneca COVID-19 vaccine (Covishield in India), covering its mechanism, safety, potential side effects like VITT, and its significance in India's vaccination efforts. Understand what you need to know.

Hello everyone! In these times, staying informed about COVID-19 vaccines is paramount. You might have heard about the AstraZeneca vaccine, also known as Vaxzevria. While it's been used in many parts of the world, it hasn't received full approval from the US FDA yet. But what does that mean for us in India, and what should you know if you've received it or are considering it? Let's break it down.
The AstraZeneca vaccine is a viral vector vaccine. Think of it like a delivery service. It uses a harmless, modified chimpanzee adenovirus (a common cold virus) to carry genetic instructions into your body. These instructions tell your cells how to make a specific piece of the coronavirus – the spike protein. Your body then recognizes this spike protein as foreign and mounts an immune response, building defences against the actual virus without you ever getting sick. This is similar to how the Johnson & Johnson vaccine works.
A significant advantage of the AstraZeneca vaccine, especially for global distribution, is its storage requirement. Unlike the Pfizer and Moderna vaccines, which need extremely cold temperatures (the 'cold chain'), the AstraZeneca vaccine can be stored in a regular refrigerator. This makes it much easier to transport and administer, particularly in regions with less developed cold chain infrastructure.
Why the US FDA Hold-Up?
The reason the AstraZeneca vaccine hasn't been fully approved by the US FDA is primarily due to data from initial large-scale trials. The FDA noted that some participants in these trials mistakenly received half doses, and the trials didn't include a sufficient number of participants over the age of 55. To ensure comprehensive safety and efficacy data, the FDA requested a new, larger trial to gather clearer information. This is a standard regulatory process aimed at ensuring the highest safety standards.
Despite the US FDA's ongoing review, major health organizations like the European Medicines Agency (EMA) and the World Health Organization (WHO) have deemed the AstraZeneca vaccine safe and effective. It continues to be recommended globally. As with any medical intervention, there's a small possibility of side effects and complications. Understanding these is key to making informed decisions.
Most vaccine side effects are mild and short-lived, indicating your immune system is building protection. These can include:
These typically resolve within a few days. However, it's important to be aware of more serious, though rare, warning signs that require immediate medical attention.
One of the more serious, albeit very rare, concerns that emerged was related to blood clots. This condition, termed Vaccine-Induced Thrombotic Thrombocytopenia (VITT), is a specific type of blood clot that occurs in unusual locations, often in the brain or abdomen, and is associated with low platelet counts. It shares some similarities with a condition called Heparin-Induced Thrombocytopenia (HITT), but critically, individuals who developed VITT had not taken heparin.
Researchers believe this VITT is an immune response triggered by the vaccine. Because the AstraZeneca vaccine uses an adenovirus vector, similar cases were observed with the Johnson & Johnson vaccine, which also uses an adenovirus. mRNA vaccines (like Pfizer and Moderna) have not shown this specific side effect, suggesting it might be linked to the adenovirus vector technology.
It's vital to put this risk into perspective. The incidence of VITT is extremely low. The benefits of vaccination in preventing severe COVID-19, hospitalization, and death far outweigh this rare risk for the vast majority of people. Public health authorities continuously monitor vaccine safety and provide updated guidance.
If you experience any of the following symptoms, especially 4 to 28 days after your vaccination, contact your doctor or seek emergency care immediately:
Important Note: If you had a severe allergic reaction or anaphylaxis after your first dose of any vaccine, do not get a second dose of that specific vaccine. Always discuss this with your doctor.
In India, the AstraZeneca vaccine is widely administered under the Covishield brand name, manufactured by the Serum Institute of India (SII). It has played a significant role in our country's vaccination drive. Millions of Indians have received Covishield, and it has been instrumental in reducing the severity of the pandemic's impact.
Diagnosing VITT involves assessing symptoms, blood tests to check platelet counts and look for clotting factors, and imaging studies to identify clot locations. Treatment typically involves stopping any anticoagulants if used, and specific medical therapies to manage the clotting and immune response. Healthcare professionals are trained to identify and manage these rare events.
While you can't 'prevent' rare side effects, staying informed and vigilant is key. If you have a history of blood clotting disorders or have concerns about vaccine safety, it's always best to discuss these with your doctor before getting vaccinated. They can provide personalized advice based on your health history.
Consult your doctor if:
Choosing a vaccine is a personal decision, and being armed with accurate information is your best tool. The AstraZeneca vaccine, or Covishield in India, has been a cornerstone of our fight against COVID-19, and understanding its profile helps us navigate our healthcare choices with confidence. Stay safe, stay informed!
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.

Chronic inflammation is the underlying driver of most major diseases — from heart disease to Alzheimer's. The right anti-inflammatory foods can meaningfully reduce systemic inflammation, and the evidence behind them is stronger than you might think.
April 13, 2026
Learn about mononucleosis (mono), its symptoms like extreme fatigue and sore throat, causes like the Epstein-Barr virus, and how to manage recovery with rest and home care. Understand diagnosis and when to seek medical help.
April 1, 2026
Explore the risks of STI transmission during hand jobs, fingering, and oral sex. Learn practical prevention tips and when to get tested to protect your sexual health.
April 1, 2026